ENX-205

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameENX-205
Drug Alias NameENX-205
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor agonistsDopamine D2 receptor antagonists +[4] 
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptorDopamine D2 receptor +[4] 
Therapy Area/IndicationsStress Disorders, Post-Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEngrail Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEngrail Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A